In the Press

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic.

New SARS-CoV-2 variants have changed the pandemic. What will the virus do next?

“A year on I’ve been proven pretty much wrong on all of it,” Holmes says.

This scientist says cleaning indoor air could make us healthier—and smarter

Joseph Allen runs a major public health research project at Harvard University, probing how indoor air quality affects human health and cognition

Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

The impact of air pollution on hospital admission for respiratory and cardiovascular diseases in an oil and gas-rich country

EXCLUSIVE: Lab discovers root cause of confusion, fatigue experienced by COVID 'long haulers'

Study casts doubt on WHO guidance on antibiotics for neonatal sepsis

New research by an international team of scientists raises questions about the recommended treatment for neonatal sepsis in low- and middle-income countries (LMICs).

Biomarker test may drive treatment considerations for most common adult leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults.1,2 Each year, approximately 20,000 Americans are diagnosed with CLL, with new cases at a rate of 4.9 per 100,000 in adult men and women.3